Marker Therapeutics (MRKR) P/E (2014 - 2026)
Marker Therapeutics (MRKR) P/E from Mar 25, 2014 to Jul 21, 2026. The TTM Marker Therapeutics (MRKR) P/E is -1.65. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Marker Therapeutics (MRKR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.65 | +8.21% |
| 2025 | -1.53 | -44.30% |
| 2024 | -2.74 | -46.27% |
| 2023 | -5.11 | +725.08% |
| 2022 | -0.62 | -67.15% |
| 2021 | -1.88 | -22.39% |
| 2020 | -2.43 | -60.37% |
| 2019 | -6.13 | +337.19% |
| 2018 | -1.40 | -62.84% |
| 2017 | -3.77 | +88.07% |
| 2016 | -2.01 | -54.32% |
| 2015 | -4.39 | +165.19% |
| 2014 | -1.66 | N/A |
Comparison Marker Therapeutics (MRKR) P/E with competitors
Marker Therapeutics (MRKR) P/E is -1.65.